Skip to main content
. 2023 May 12;10(1):e002292. doi: 10.1136/openhrt-2023-002292

Figure 5.

Figure 5

Decision curves for the new and conventional risk scores. (A) Decision curves for the new and conventional (CHADS2, CHA2DS2-VASc and HAS-BLED scores) risk scores to predict NACE incidence in patients with AF and stable CAD. (B) A 10-fold cross-validated decision curve for the new risk score to obtain a bias-corrected decision curve. AF, atrial fibrillation; CAD, coronary artery disease; NACE, net adverse clinical event; CHADS2, Congestive heart failure, Hypertension, Age ≥75 y, Diabetes mellitus, Stroke or TIA; CHA2DS2-VASc, Congestive heart failure, Hypertension, Age ≥75 y, Diabetes mellitus, Stroke or TIA, Vascular disease, Age 65-74 y, Sex category [female]; HAS-BLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding, Labile INR, Elderly, Drugs.